Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery ...

Novartis’ Kisqali receives US FDA approval to reduce risk of recurrence in people with HR+/HER2- early breast cancer: Basel Thursday, September 19, 2024, 13:00 Hrs [IST] Novarti ...

Basel: Novartis has announced that the US Food and Drug Administration (FDA) has approved Kisqali (ribociclib) in combination ...

Ad hoc announcement pursuant to Art. 53 LR Broad indication in HR+/HER2- stage II and III early breast cancer (EBC) at high risk of recurrence approximately doubles population eligible for CDK4/6 inhi ...

While rivals like Toyota, Ford and Mazda have vacated the cheaper end of the market, the Chinese/British brand (depending who you ask) has happily and successfully filled the void. Coinciding with ...

JSW MG Motor has dropped another teaser of the Windsor EV ahead of its official launch on September 11. This is the first time MG Motor has revealed the design of the Crossover Utility Vehicle.

The new teaser shows the exterior design, which is similar to the international-spec Wuling Cloud EV on which it is based The Windsor EV will be MG's third EV in India. New teaser confirms LED ...

Hungary has missed the first deadline to pay the €200 million fine imposed by the European Court of Justice (ECJ). It's prompted Brussels to send a second payment request and it's set the stage ...

The 2025 MG HS family SUV has arrived in Australia with price rises of up to $7000 – or 20 per cent – to offset a larger body and new features. Prices are up by between $4000 and $7000 ...